UBS Group’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-63,645
| Closed | -$64 | – | 9159 |
|
|
2024
Q2 | $64 | Buy |
63,645
+63,001
| +9,783% | +$63 | ﹤0.01% | 8051 |
|
|
2024
Q1 | $87 | Sell |
644
-790
| -55% | -$107 | ﹤0.01% | 7689 |
|
|
2023
Q4 | $103 | Buy |
+1,434
| New | +$103 | ﹤0.01% | 7716 |
|
|
2023
Q3 | – | Sell |
-19,692
| Closed | -$2.7K | – | 8843 |
|
|
2023
Q2 | $2.7K | Buy |
+19,692
| New | +$2.7K | ﹤0.01% | 6630 |
|
|
2022
Q3 | – | Sell |
-2,929
| Closed | -$1K | – | 9916 |
|
|
2022
Q2 | $1K | Sell |
2,929
-120
| -4% | -$41 | ﹤0.01% | 9000 |
|
|
2022
Q1 | $1K | Buy |
3,049
+2,254
| +284% | +$739 | ﹤0.01% | 8921 |
|
|
2021
Q4 | $1K | Sell |
795
-433
| -35% | -$545 | ﹤0.01% | 8935 |
|
|
2021
Q3 | $2K | Buy |
1,228
+611
| +99% | +$995 | ﹤0.01% | 7859 |
|
|
2021
Q2 | $1K | Buy |
617
+545
| +757% | +$883 | ﹤0.01% | 8099 |
|
|
2021
Q1 | $0 | Buy |
+72
| New | – | ﹤0.01% | 8324 |
|